Scheduling Nuclear Medicine Studies That Use PET/CT

Type of PET/CT scan (referrals must be reviewed by nuclear medicine consultant)Scans that can be booked and performed as requested (unless patient is at risk of COVID-19 infection) Scans that require liaison with clinical team for canceling or rescheduling (inform patient)
Oncology18F-FDG for staging, restaging, response assessment, and radiotherapy planning18F-FDG, 68Ga-DOTATATE/DOTATOC, 18F-PSMA, 68Ga-PSMA, 18F-choline, 18F-NaF, or 18F-DOPA for follow-up evaluation
18F-PSMA, 68Ga-PSMA, or 18F-choline for biochemical recurrence
68Ga-DOTATATE/DOTATOC for staging, restaging, and selecting patients for PRRT
18F-NaF for bone metastases
18F-DOPA for diagnosis and staging
Nononcology18F-FDG for pyrexia of unknown origin in COVID-19–negative patients, for sepsis, for viability testing in symptomatic patients awaiting CABG, for suspected device or prosthetic infection, or for cardiac sarcoidosis18F-FDG for known sarcoidosis in patients on treatment, for polymyalgia rheumatica, or for follow-up of known cardiac sarcoidosis in patients on treatment
  • These are examples based on consensus only, and responsibility lies with each institution or hospital to ensure its written policy adheres to that outlined by national public health guidance in its respective country and hospital.

  • FDG = fluorodeoxyglucose; PSMA = prostate-specific membrane antigen; PRRT = peptide receptor radionuclide therapy; DOPA = 3,4-dihydroxyphenylalnine; CABG = coronary artery bypass grafting; NaF = sodium fluoride.